P.F.A. Safety in 40000 Patients 01/22/26
Welcome to Cardiology Today â Recorded January 22, 2026. This episode summarizes 5 key cardiology studies on topics like Pulsed field ablation and chlorhexidine. Key takeaway: P.F.A. Safety in 40000 Patients.
Article Links:
Article 1: Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study. (Journal of the American College of Cardiology)
Article 2: Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US. (Journal of the American College of Cardiology)
Article 3: Association of Autonomic Dysfunction With Long COVID: Evaluation Using Quantitative Autonomic Testing. (Journal of the American College of Cardiology)
Article 4: Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial. (Journal of the American College of Cardiology)
Article 5: Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP Study. (Journal of the American College of Cardiology)
Full episode page: https://podcast.explainheart.com/podcast/p-f-a-safety-in-40000-patients-01-22-26/
đ Featured Articles
Article 1: Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study.
Journal: Journal of the American College of Cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41562534
Summary: Cardiac resynchronization therapy implantation is associated with the highest infection risk among all cardiac implantable electronic devices. Prior research comparing alcohol-based povidone-iodine and chlorhexidine for skin antisepsis in general surgical-site infections has yielded conflicting evidence. The optimal antiseptic strategy for preventing infections specifically during cardiac resynchronization therapy implantation has remained inadequately studied. This prospective randomized study directly compared the effectiveness of two percent alcohol-based chlorhexidine with povidone-iodine alcohol solution to address this critical clinical gap.
Article 2: Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US.
Journal: Journal of the American College of Cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41389071
Summary: Pulsed field ablation for atrial fibrillation demonstrates a promising safety profile, including reduced risks of esophageal injury, pulmonary vein stenosis, and phrenic nerve injury. Identifying rare complications for new technologies necessitates extremely large patient cohorts. The M.A.N.I.F.E.S.T.-U.S. multicenter retrospective analysis evaluated the real-world utilization and comprehensive safety profile of the pentaspline pulsed field ablation catheter. This extensive study included data from over 40000 patients treated across the United States.
Article 3: Association of Autonomic Dysfunction With Long COVID: Evaluation Using Quantitative Autonomic Testing.
Journal: Journal of the American College of Cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41369621
Summary: Long COVID syndrome is characterized by persistent symptoms such as heart palpitations, lightheadedness, and fatigue, even after acute COVID-19 infection. Autonomic dysfunction is recognized as a key component of long COVID, yet its specific nature and severity have remained largely undefined. This study performed quantitative autonomic testing to compare autonomic function measures in patients with long COVID against control subjects. The research also included a comparison with individuals diagnosed with pure autonomic failure, providing a comprehensive assessment of distinct autonomic disturbances.
Article 4: Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial.
Journal: Journal of the American College of Cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41217320
Summary: The V.A.N.I.S.H. two multicenter randomized trial compared catheter ablation to antiarrhythmic drugs for patients with prior myocardial infarction and ventricular tachycardia. Patient randomization in the main trial was stratified according to drug eligibility based on specific clinical criteria. This prespecified substudy directly compared the clinical outcomes of catheter ablation versus antiarrhythmic drugs within these distinct drug eligibility strata. The analysis included patients defined as eligible for sotalol versus ablation based on their clinical characteristics.
Article 5: Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP Study.
Journal: Journal of the American College of Cardiology
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41159983
Summary: Polygenic risk scores demonstrate considerable promise for risk stratification and screening in cardiovascular diseases, including atrial fibrillation. This prespecified post hoc analysis of the randomized L.O.O.P. study investigated the efficacy of atrial fibrillation screening for stroke prevention when guided by a polygenic risk score for atrial fibrillation. The analysis included 5656 individuals, all of whom were atrial fibrillation-naive and aged 70 years or older. This research evaluated the utility of genetically-informed screening strategies within a high-risk population for preventing stroke.
đ Transcript
Today’s date is January 22, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study. Cardiac resynchronization therapy implantation is associated with the highest infection risk among all cardiac implantable electronic devices. Prior research comparing alcohol-based povidone-iodine and chlorhexidine for skin antisepsis in general surgical-site infections has yielded conflicting evidence. The optimal antiseptic strategy for preventing infections specifically during cardiac resynchronization therapy implantation has remained inadequately studied. This prospective randomized study directly compared the effectiveness of two percent alcohol-based chlorhexidine with povidone-iodine alcohol solution to address this critical clinical gap.
Article number two. Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US. Pulsed field ablation for atrial fibrillation demonstrates a promising safety profile, including reduced risks of esophageal injury, pulmonary vein stenosis, and phrenic nerve injury. Identifying rare complications for new technologies necessitates extremely large patient cohorts. The M.A.N.I.F.E.S.T.-U.S. multicenter retrospective analysis evaluated the real-world utilization and comprehensive safety profile of the pentaspline pulsed field ablation catheter. This extensive study included data from over 40000 patients treated across the United States.
Article number three. Association of Autonomic Dysfunction With Long COVID: Evaluation Using Quantitative Autonomic Testing. Long COVID syndrome is characterized by persistent symptoms such as heart palpitations, lightheadedness, and fatigue, even after acute COVID-19 infection. Autonomic dysfunction is recognized as a key component of long COVID, yet its specific nature and severity have remained largely undefined. This study performed quantitative autonomic testing to compare autonomic function measures in patients with long COVID against control subjects. The research also included a comparison with individuals diagnosed with pure autonomic failure, providing a comprehensive assessment of distinct autonomic disturbances.
Article number four. Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial. The V.A.N.I.S.H. two multicenter randomized trial compared catheter ablation to antiarrhythmic drugs for patients with prior myocardial infarction and ventricular tachycardia. Patient randomization in the main trial was stratified according to drug eligibility based on specific clinical criteria. This prespecified substudy directly compared the clinical outcomes of catheter ablation versus antiarrhythmic drugs within these distinct drug eligibility strata. The analysis included patients defined as eligible for sotalol versus ablation based on their clinical characteristics.
Article number five. Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP Study. Polygenic risk scores demonstrate considerable promise for risk stratification and screening in cardiovascular diseases, including atrial fibrillation. This prespecified post hoc analysis of the randomized L.O.O.P. study investigated the efficacy of atrial fibrillation screening for stroke prevention when guided by a polygenic risk score for atrial fibrillation. The analysis included 5656 individuals, all of whom were atrial fibrillation-naive and aged 70 years or older. This research evaluated the utility of genetically-informed screening strategies within a high-risk population for preventing stroke.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
Pulsed field ablation, chlorhexidine, polygenic risk score, stroke prevention, pulmonary vein stenosis, antiarrhythmic drugs, Ventricular tachycardia, povidone-iodine, myocardial infarction, heart palpitations, atrial fibrillation, esophageal injury, Atrial fibrillation, skin antisepsis, Cardiac resynchronization therapy, surgical-site infection, quantitative autonomic testing, catheter ablation, amiodarone, safety profile, L.O.O.P. study, Long COVID, autonomic dysfunction, sotalol, screening, fatigue.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow